Entrada Therapeutics Inc (TRDA)

19.04 -0.92 (-4.61%) USD  |  NASDAQ  |  Nov 14, 16:00
19.04 0.00 (0.00%) After-Hours: 20:00
More

Entrada Therapeutics Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for TRDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Non-Current Deferred Revenue (Quarterly) Data

View and export this data back to 2022. Upgrade now.
Date Value
September 30, 2024 --
June 30, 2024 --
March 31, 2024 --
December 31, 2023 --
Date Value
September 30, 2023 --
June 30, 2023 --
March 31, 2023 --
December 31, 2022 --

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

--
Minimum
Dec 2022
Upgrade
Maximum
Jun 2023
Upgrade
Average
Upgrade
Median
Mar 2024

Non-Current Deferred Revenue (Quarterly) Benchmarks

Fulcrum Therapeutics Inc --
Catalyst Pharmaceuticals Inc --
Vertex Pharmaceuticals Inc --
Assembly Biosciences Inc Upgrade
Sarepta Therapeutics Inc Upgrade